Related Experiment Videos

Clinical relevance of antibiotic-induced endotoxin release in patients undergoing hepatic resection

M Ishikawa1, T Miyauchi, K Yagi

  • 1First Department of Surgery, University of Tokushima, School of Medicine, 3-18-15, Kuramoto-cho, Tokushima City 770, Japan.

World Journal of Surgery
|December 5, 1998
PubMed

Insights

Antibiotic-induced endotoxin release was studied in hepatic resection patients. Results indicate no significant endotoxin elevation, suggesting clinical implications are unlikely due to continuous endotoxin scavenging.

Area of Science:

  • Hepatobiliary Surgery
  • Pharmacology
  • Infectious Disease

Background:

  • Antibiotics targeting penicillin-binding protein 3 (PBP3) may increase endotoxin release compared to PBP2 binders.
  • Hepatic resection is a complex surgery with potential for complications.

Purpose of the Study:

  • To investigate the clinical impact of antibiotic-induced endotoxin release following hepatic resection.
  • To compare endotoxin levels and patient outcomes based on antibiotic class.

Main Methods:

  • Forty-five patients undergoing hepatic resection were divided into two groups based on antibiotic binding (PBP3 vs. PBP2/PBP3).
  • Postoperative complications, liver function, and inflammatory mediators (endotoxin, cytokines) were monitored.

Main Results:

  • No significant difference in postoperative complications or cytokine levels between antibiotic groups.
  • No significant elevation in peripheral blood endotoxin was detected, despite some sepsis-related deaths.

Conclusions:

  • Clinical antibiotic-induced endotoxin release appears unlikely after hepatic resection.
  • Continuous endotoxin scavenging from peripheral blood may mitigate effects regardless of antibiotic choice.

Related Concept Videos